Evidence map›Paper›PMID 33046467›Full record

ArticleBMJ open2020

Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma atient-centred Intervention Network (SPIN) Cohort Study.

Sophia J Sommer, Daphna Harel, Linda Kwakkenbos, Marie-Eve Carrier, Shadi Gholizadeh, Karen Gottesman, Catarina Leite, Vanessa L Malcarne, Brett D Thombs, SPIN Investigators

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sophia J SommerApplied Statistics, Social Science and Humanities, New York University, New York, New York, USA.
Daphna HarelApplied Statistics, Social Science and Humanities, New York University, New York, New York, USA.
Linda KwakkenbosBehavioral Science Institute, Radboud University, Nijmegen, The Netherlands.
Marie-Eve CarrierLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Shadi GholizadehSan Diego Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California, San Diego, California, USA.
Karen GottesmanScleroderma Foundation, Los Angeles, California, USA.
Catarina LeiteSchool of Psychology, University of Minho, Braga, Portugal.
Vanessa L MalcarneSan Diego Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California, San Diego, California, USA.
Brett D ThombsLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada brett.thombs@mcgill.ca.ORCID 0000-0002-5644-8432
SPIN Investigators

Funding

Institutional Career Development CoreKL2TR003168 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILLER, CHARLES C · 2019 to 2023
$4.9M
CIHR PJT-148504CIHR PJT-149073CIHR SCT-162963CIHR TR3-119192NCATS NIH HHS KL2 TR003168
6 · The paper itself

Abstract

objectivesThe Social Appearance Anxiety Scale (SAAS) is a 16-item questionnaire developed to evaluate fear of appearance-based evaluation by others. The primary objective of this research was to investigate the existence of differential item functioning (DIF) for the 16 SAAS items, comparing patients who completed the SAAS in English and French, either to confirm that scores are comparable or provide guidance on calculating comparable scores. A secondary research objective was to investigate the existence of DIF based on sex and disease status. A tertiary research objective was to assess DIF related to language, sex, and disease status on the recently developed SAAS-5.

designThis was a cross-sectional analysis using baseline data from patients enrolled in the Scleroderma Patient-centred Intervention Network (SPIN).

settingSPIN patients included in the present study were enrolled at 43 centres in Canada, USA, UK, France and Australia, with questionnaires completed in April 2014 to July 2019.

participants1640 SPIN patients completed the SAAS in French (n=600) or English (n=1040). PRIMARY AND SECONDARY MEASURES: The SAAS was collected along with demographic and disease characteristics.

resultsSix items were identified with statistically significant language-based DIF, four with sex-based DIF and one with disease type-based DIF. However, factor scores before and after accounting for DIF were similar (Pearson correlation >0.99), and individual score differences were small. This was true for both the full and shortened versions of the SAAS.

conclusionSAAS and SAAS-5 scores are comparable across language, sex, and disease-type, despite small differences in how patients respond to some items.

Indexed as

AnxietyFearAustraliaCanadaCohort StudiesCross-Sectional StudiesFranceHumansPsychometricsSurveys and Questionnairesanxiety disordersrheumatologystatistics & research methods

Identifiers

PMID33046467
PMCPMC7552836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.